1. Home
  2. LEE vs TNYA Comparison

LEE vs TNYA Comparison

Compare LEE & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$8.22

Market Cap

160.1M

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.69

Market Cap

178.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
TNYA
Founded
1890
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.1M
178.5M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
LEE
TNYA
Price
$8.22
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
92.4K
5.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
$543,955,000.00
N/A
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
$1,456.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$0.36
52 Week High
$10.81
$2.35

Technical Indicators

Market Signals
Indicator
LEE
TNYA
Relative Strength Index (RSI) 51.69 45.11
Support Level $8.06 $0.66
Resistance Level $9.74 $0.94
Average True Range (ATR) 0.62 0.06
MACD -0.11 -0.02
Stochastic Oscillator 38.13 26.18

Price Performance

Historical Comparison
LEE
TNYA

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: